Related by context. All words. (Click for frequent words.) 73 geldanamycin 73 Hsp# inhibitor 72 orally administered inhibitor 72 MEK inhibitors 71 proteasome inhibitors 70 anticancer agents 70 Hsp# inhibition 70 ansamycin 70 VEGF inhibitors 69 ENMD # 69 polymerase inhibitors 69 immunomodulatory 69 JAK inhibitors 69 kinase inhibitor 69 HCV protease 69 SERMs 69 mTOR inhibitors 68 small molecule inhibitors 68 selective inhibitors 68 proteasome inhibitor 68 Tyrima 68 Xanafide 68 epothilones 68 Preclinical studies suggest 68 cilengitide 68 receptor tyrosine kinase inhibitor 67 SARMs 67 JAK1 67 selective kinase inhibitor 67 GMX# 67 CYT# potent vascular disrupting 67 endothelin receptor antagonists 67 HDAC inhibitors 67 PI3K inhibitors 67 induce apoptosis 67 orally bioavailable 67 immunomodulating 67 partial agonist 67 selective antagonist 67 immune modulating 67 Aurora kinase 67 multi kinase inhibitor 67 vascular disrupting agent 67 oxidative stress inducer 67 Sphingomab 67 HCV protease inhibitors 67 CYC# 67 investigational monoclonal antibody 67 JAK2 inhibitor 67 IAP inhibitors 66 immune stimulatory 66 imatinib Gleevec ® 66 small molecule inhibitor 66 anti proliferative 66 taxanes 66 protein kinase inhibitor 66 sulindac 66 NS#/#A protease 66 HSP# inhibitor 66 Bezielle 66 anti angiogenic agents 66 sodium glucose cotransporter 66 anti fibrotic 66 epothilone 66 JAK2 inhibitors 66 novel peptide 66 highly selective inhibitor 66 immune modulators 66 targeting CD# 66 oral prodrug 66 OXi# 66 delta isoform 66 JAK inhibitor 66 nucleoside analog 66 erlotinib Tarceva ® 66 PI3K inhibitor 66 PARP inhibitors 66 Symadex 66 Seliciclib 66 echinocandins 66 interferon IFN 66 #HT#A 66 nucleoside analogues 66 receptor inhibitor 65 anti mitotic 65 Thiovir 65 5 HT2A inverse 65 CORT # 65 reversible inhibitor 65 angiogenesis inhibitor 65 HCV polymerase inhibitors 65 HDAC inhibitor 65 investigational humanized monoclonal antibody 65 Hsp# chaperone system 65 PDE4 inhibitor 65 insulin sensitizers 65 nucleoside analogs 65 multitargeted 65 AKT inhibitor 65 selective inhibition 65 pan HDAC inhibitor 65 Archexin 65 CCR9 antagonist 65 HIV integrase inhibitors 65 BCR ABL inhibitors 65 antiangiogenic 65 JAK3 65 anti secretory 65 Sym# 65 vinca alkaloid 65 kinase inhibitors 65 anti angiogenic 65 CCR2 65 demonstrated antitumor activity 65 small molecule tyrosine 65 anti leukemic 65 peripherally acting 65 selective modulator 65 cyclophilin inhibitor 65 FGFR 65 BAY #-# 65 PDE4 inhibitors 65 humanized monoclonal antibody 65 interferon lambda 65 deacetylase inhibitors 65 insulin sensitizing 65 Squalamine 65 thrombopoietin 65 HDAC inhibition 65 potent anticancer 65 vascular disrupting agents 65 VDAs 65 RNA antagonist 65 tyrosine kinase inhibitor 65 chemotherapeutics 65 immunomodulation 65 Epothilones 65 PI3K/mTOR 64 NNRTIs 64 docetaxel Taxotere R 64 obatoclax 64 signal transduction inhibitor 64 humanized antibody 64 systemically administered 64 liposomal formulation 64 selective inhibitor 64 IAP inhibitor 64 novel immunomodulatory 64 CTAP# Capsules 64 HDACi 64 myeloproliferative diseases 64 M2 subunit 64 histone deacetylase 64 Factor VIIa 64 5 HT2A receptor 64 potent inhibitors 64 LHRH antagonists 64 cytoprotective 64 potent inhibitor 64 HuLuc# 64 histone deacetylases 64 histone deacetylase inhibitors 64 Panzem R NCD 64 receptor agonists 64 OMP #M# 64 small molecule activators 64 Debio 64 immunostimulatory 64 antisense oligonucleotide 64 neuroprotective properties 64 CDK inhibitor 64 radiation sensitizer 64 Nanobody ® 64 cyclin dependent kinase inhibitor 64 RGB # 64 Bicifadine 64 Pathway Inhibitor 64 NXL# 64 PSN# [002] 64 alvespimycin 64 non nucleoside HCV 64 selective antagonists 64 vinca alkaloids 64 CCX# 64 AEG# 64 immunomodulator 64 Ganetespib 64 PXD# 64 Blinatumomab 64 huC# DM4 64 BMS # 64 LY# [003] 64 Protein Kinase C 64 kinase inhibition 64 RNAi therapeutic targeting 64 metaglidasen 64 reverse transcriptase inhibitors 64 Telintra 64 selectively inhibits 64 HDAC enzymes 64 pertuzumab 64 leukemia AML 63 DFMO 63 neratinib 63 Guanilib 63 histone deacetylase HDAC inhibitor 63 Smac mimetics 63 renin inhibitor 63 Nanobodies 63 prodrugs 63 alkylating agent 63 humanised monoclonal antibody 63 oxazolidinone 63 AMPK activators 63 thalidomide Thalomid 63 XmAb# 63 receptor antagonists 63 GSK3B 63 immunotoxin 63 myelofibrosis polycythemia vera 63 Tß4 63 oncolytic 63 evaluating tivozanib 63 CA4P 63 xenograft models 63 SAR# [004] 63 Zolinza 63 pro apoptotic 63 receptor agonist 63 Orally administered 63 FLT3 63 antifolates 63 antithrombotic 63 mTOR inhibitor 63 Dapagliflozin 63 lupus nephritis 63 renin inhibitors 63 enzyme inhibitors 63 antiproliferative 63 antitumor 63 selective orally bioavailable 63 novel VDA molecule 63 selective inverse agonist 63 EGFR inhibitors 63 Fc fusion protein 63 tyrosine kinase inhibitors 63 PRT# 63 HGS# 63 A3 adenosine receptor 63 Pimavanserin 63 polymerase inhibitor 63 docetaxel Taxotere ® 63 paclitaxel Taxol 63 Enzastaurin 63 cannabinor 63 uric acid lowering 63 PEG SN# 63 preclinically 63 LEP ETU 63 visilizumab 63 TLR9 agonist 63 HDAC 63 preclinical compounds 63 NS4A 63 chemopreventive agent 63 forodesine 63 gamma secretase inhibitor 63 HMG CoA reductase inhibitors 63 humanized monoclonal 63 elotuzumab 63 LNP formulations 63 selectively inhibit 63 molecularly targeted 63 microtubule targeting 63 #beta HSD1 63 cleavable linker 63 TLR8 63 oral JAK1 63 targeted radiotherapeutic 63 aurora kinase 63 tigecycline 63 GLYX 63 peptide antigens 63 microtubule inhibitor 63 dasatinib Sprycel 63 nucleoside 63 selective agonist 63 Aurora kinase inhibitor 63 retaspimycin hydrochloride 63 Darinaparsin 63 Voreloxin 63 ganetespib 63 HGS ETR1 63 XL# XL# 63 TG# [003] 63 Hedgehog signaling pathway 63 selective androgen receptor modulator 63 Aplidin 63 Romidepsin 62 potent antiproliferative 62 Vidaza azacitidine 62 S#P# 62 anticancer activity 62 VEGF receptor 62 nucleotide analogs 62 histone deacetylase HDAC inhibitors 62 p# inhibitor 62 rNAPc2 62 T#I mutant 62 potently inhibit 62 JAK#/JAK# 62 favorable pharmacokinetic profile 62 antitumoral 62 IGF 1R 62 antifungal drugs 62 AEGR 62 oral nucleoside analogue 62 imatinib Gleevec 62 seliciclib 62 chimeric monoclonal antibody 62 sorafenib Nexavar 62 MTP inhibitor 62 pharmacodynamic biomarkers 62 Dasatinib 62 #ME# 62 CD# monoclonal antibody 62 REP# 62 anticancer therapy 62 Hedgehog pathway 62 HuMax EGFr 62 HGS ETR2 62 PNP inhibitor 62 5 HT2A serotonin 62 BRAF inhibitor 62 MCSP respectively 62 HepDirect prodrug 62 sPLA2 62 echinocandin 62 IMiDs ® 62 Epratuzumab 62 brain penetrant 62 PDGFR 62 TRV# [001] 62 pharmacokinetic properties 62 intranasal formulation 62 Curaxins 62 nucleosides 62 integrase inhibitors 62 mGluR5 antagonist 62 Panzem R 62 isoform selective 62 delafloxacin 62 anticancer therapeutics 62 P#X# 62 fosbretabulin 62 TELINTRA 62 cyclin dependent kinases CDKs 62 ALN PCS 62 CCR5 antagonist 62 NGX# 62 ceftazidime 62 ocular formulation 62 CRTH2 62 vidofludimus 62 radezolid 62 SAR# [002] 62 TRAIL induced apoptosis 62 Tumor Necrosis Factor 62 PS# [001] 62 Anticalins R 62 anticancer therapies 62 humanized anti 62 direct thrombin inhibitors 62 non nucleoside inhibitor 62 histone deacetylase HDAC 62 Akt inhibitor 62 antagomirs 62 nucleoside reverse transcriptase inhibitor 62 Vidofludimus 62 somatostatin 62 epithelial tumors 62 MLN# 62 FK# 62 factor TNF 62 lipid lowering therapies 62 metastatic RCC 62 5 HT2B receptor 62 BAL# [001] 62 ARIKACE ™ 62 Aliskiren 62 PEP# [003] 62 chemopreventive 62 ATL# [001] 62 Maribavir 62 nanomolar 62 myeloproliferative disorders 62 immunoregulatory 62 depsipeptide 62 potent inhibition 62 inverse agonist 62 preclinical models 62 Nanobody 62 p# inhibitors 62 CBLC# 62 Perifosine 62 mitochondrial toxicity 62 small molecule glucokinase 62 atacicept 62 ADP receptor antagonist 62 hematological malignancies 62 Apoptone 62 teriflunomide 62 anti CD3 62 KSP inhibitors 62 triphendiol 62 #HT# 62 hypoxia activated prodrug 62 XL# XL# XL# XL# 62 thrombin receptor 62 erythropoietic 62 siRNA therapeutics 62 peptibody 62 Omacetaxine 62 YONDELIS 62 MAGE A3 ASCI 62 fibrotic disease 62 IMiDs R 62 Factor Receptor 62 generation purine nucleoside 62 Carfilzomib 62 Azedra 62 Delafloxacin 62 small molecule chemotherapeutic 62 Interferon alpha 62 RNA antagonists 62 tiapamil 62 PLK1 62 highly selective endothelin 61 iSONEP 61 milatuzumab 61 PI3K 61 CEQ# 61 phosphate S1P 61 selective estrogen receptor 61 targeted antifolate 61 TRAIL receptor antibodies 61 HDACs 61 CD# CEA 61 VEGF receptors 61 generation Hsp# inhibitor 61 pharmacokinetic interactions 61 humanized monoclonal antibodies 61 fusion proteins 61 PTP 1B 61 regorafenib 61 protein tyrosine phosphatase 1B 61 2 methoxyestradiol 61 alagebrium 61 INCB# [003] 61 peptidic 61 synthetic retinoid 61 Alfacell proprietary ribonuclease 61 antisense drugs 61 NEUGENE 61 castrate resistant prostate cancer 61 HCV protease inhibitor 61 oral antiviral 61 vemurafenib 61 lintuzumab SGN 61 daptomycin 61 endothelin receptor 61 diabetic neuropathic pain 61 PRTX 61 integrase inhibitor 61 MMP inhibitors 61 marketed EGFR 61 antibody MAb 61 MKC# MT 61 HDAC Inhibitor 61 LY# [002] 61 CD# antibodies 61 gamma secretase inhibitors 61 nanomolar range 61 novel histone deacetylase 61 sunitinib Sutent ® 61 immunomodulators 61 cytotoxic 61 sphingosine 1 61 mertansine 61 somatostatin analogue 61 splice variants 61 radiolabeled 61 non nucleoside 61 immune modulator 61 mGluR2 NAM 61 VEGFR2 61 chemotherapeutic drug 61 EGFr 61 OncoVEX 61 drug zotarolimus 61 secretory phospholipase A2 61 lenalidomide dexamethasone 61 clinically validated targets 61 small molecule agonists 61 tanespimycin 61 GPCR targets 61 eniluracil 61 romazarit 61 Atrasentan 61 Janus Kinase 61 hematological cancers 61 vorinostat 61 PI3K/Akt pathway inhibitor 61 glucagon receptor 61 selective adenosine 61 MEK inhibitor 61 rifamycin 61 anti EGFR antibody 61 INCB# [001] 61 protease inhibitors 61 Fludara ® 61 telomerase inhibitor 61 Daclizumab 61 bortezomib Velcade 61 RAF kinase 61 PEGylated Fab fragment 61 antisense inhibitors 61 anti amnesic 61 TRAIL R2 61 anticancer agent 61 pharmacologic 61 TLR9 agonists 61 cancer immunotherapies 61 tezampanel 61 XL# anticancer compounds 61 TKB# 61 Onconase 61 varespladib 61 RNAi therapeutic targeting PCSK9 61 Anticalins 61 c Raf kinase 61 histone deacetylase inhibitor 61 ocrelizumab 61 heavily pretreated 61 GAP #B# 61 adecatumumab 61 Ceflatonin 61 corticosteroid dexamethasone 61 flavopiridol 61 MUC1 61 Exelixis compounds 61 volociximab 61 anticoagulant reversing agent 61 ErbB3 61 Abiraterone acetate 61 familial amyloidotic polyneuropathy FAP 61 AAG geldanamycin analog 61 Tarvacin 61 Hsp# Inhibitor 61 Cloretazine R 61 beta interferons 61 basal cell carcinoma BCC 61 fluoroquinolone antibiotic 61 class mGluR5 inhibitor 61 liposomal 61 Mipomersen 61 nucleotide analog 61 Myolimus 61 selectively inhibited 61 targeting PCSK9 61 Abl 61 inhibitor RG# 61 prescribed proton pump 61 ISIS # 61 Gleevec resistant 61 prostanoid 61 S/GSK# 61 elvitegravir 61 CD# expressing 61 taxol 61 ESBA# 61 generation nucleoside analog 61 GDIR 61 lomitapide 61 panitumumab Vectibix 61 pegylated 61 inhaled formulation 61 lumiliximab 61 LymphoStat B belimumab 61 PDE# 61 cMET 61 mGluR5 NAM 61 anti angiogenic drugs 61 small molecule defensin 61 torezolid 61 epigenetic therapies 61 hypereosinophilic syndrome 61 elvucitabine 61 ara C 61 TriRima 61 activin receptor type 61 ATL/TV# 61 talactoferrin 61 poly ADP ribose polymerase 61 AZT zidovudine Retrovir 61 Serdaxin 61 MDV# 61 cetuximab Erbitux R 61 Pazopanib 61 resolvins 61 AT1R 61 AtuRNAi 60 anti angiogenic agent 60 isotypes 60 TPI ASM8 60 Ophena TM 60 G Protein Coupled 60 Annamycin 60 trans retinoic acid ATRA 60 solithromycin 60 ARRY 60 axitinib 60 IMC A# 60 kallikrein 60 lipopeptides 60 Gefitinib 60 Multimeric 60 Clusterin 60 nucleoside analogue 60 rifamycins 60 Angiolix 60 FVIIa 60 orally bioavailable mimics 60 squalamine 60 idarubicin 60 antisense 60 anticancer compounds 60 CGEN # 60 ALN TTR 60 Talabostat 60 effector function 60 bioactive lipids 60 inhibitor PPI 60 androgen receptor AR 60 antisense oligonucleotides 60 PI3 kinase 60 histone methyltransferases HMTs 60 skeletal metastases 60 PEGylated 60 Chemokine Receptor 60 gemcitabine Gemzar 60 antimitotic 60 tubulin inhibitor 60 IFN alpha 60 Tasimelteon 60 humanized antibodies 60 TrkA 60 DHFR 60 DXL# 60 Delta opioid receptor 60 ALN TTR# 60 Tarvacin Anti Viral 60 MTP inhibitors 60 enzastaurin 60 receptor modulators 60 SinuNase ™ 60 Pharmacokinetics PK 60 Src inhibitors 60 mycophenolate mofetil 60 OXIGON TM 60 riociguat 60 XL# inhibits 60 chemopreventive agents 60 TRX1 60 Radezolid 60 HSP# inhibitors 60 calcineurin inhibitors 60 estramustine 60 CG# [003] 60 immunomodulatory therapy 60 proliferative diseases 60 TRIOLEX 60 peroxisome proliferator activated 60 siRNA compounds 60 IL 1β 60 INS# [001] 60 multikinase inhibitor 60 EGFR HER2 60 therapeutic monoclonal antibody 60 HCV polymerase 60 plasma kallikrein inhibitor 60 IgG1 60 GRN#L 60 potently inhibited 60 siRNA therapeutic 60 antibody fragment 60 Vicinium TM 60 azoles 60 5 HT4 receptor 60 phosphatases 60 preclinical studies 60 BMN 60 IMA# 60 Pertuzumab 60 GHRH 60 SinuNase TM 60 tumor vascular disrupting 60 small molecule modulators 60 BAL# [002] 60 macrolides 60 Actilon 60 PDGF receptor 60 5 HT6 60 pegylated interferons 60 EP1 receptor 60 luteinizing hormone releasing 60 DCCR 60 metalloprotease 60 EGFR tyrosine kinase inhibitors 60 BRAF kinase 60 Sapacitabine 60 adenoviral 60 VEGF inhibitor 60 pomalidomide 60 PARP inhibitor 60 catalytic antioxidant compounds 60 serine protease 60 cytostatic 60 amphotericin B 60 SLx 60 Epothilone D 60 pradefovir 60 retapamulin 60 bendamustine 60 TLR8 agonist 60 chemokine receptor 60 velafermin 60 NMDA antagonist 60 dasatinib Sprycel ® 60 ASONEP 60 FOLFOX6 chemotherapy regimen 60 AQ4N 60 entinostat 60 tezampanel NGX# 60 Solulin 60 Tarvacin TM 60 developing Bicifadine serotonin 60 dacetuzumab 60 tumor xenograft models 60 Receptor Antagonist 60 antifibrotic 60 Vidaza ® 60 small molecule 60 Synavive 60 Aurora Kinase 60 anti CD# antibodies 60 ISTODAX 60 Kinase Inhibitor 60 SGLT2 60 exon skipping 60 IgG1 antibody 60 triggers apoptosis programmed 60 Aflibercept 60 potent antiviral 60 ErbB 60 TKM ApoB 60 ErbB3 HER3 60 antibody MT# 60 PDE4 60 HGS ETR1 mapatumumab 60 taxane resistant 60 receptor partial agonist 60 PPARγ 60 HDAC6 60 kidney urologic 60 LHRH receptor positive 60 tyrosine kinase inhibitor TKI 60 #I TM# 60 CCR5 antagonists 60 muscarinic 60 immuno modulatory 60 fenretinide 60 APOPTONE 60 TÎ ² 4 60 FAAH 60 LymphoStat B TM 60 Janus kinase 60 ON #.Na 60 quinolones 60 pertussis toxin 60 pathophysiological effects 60 OMNARIS HFA 60 antibody therapeutics 60 Mitoxantrone 60 antitumor activity 60 GLPG# 60 gefitinib Iressa 60 monoclonal anti 60 tumor subtypes 60 anionic backbone 60 TNF Tumor Necrosis Factor 60 CB2 receptor 60 bexarotene 60 DMAG 60 retaspimycin 60 Kinoid 60 oritavancin 60 androgen receptor antagonist 60 gemcitabine Gemzar ® 60 zanolimumab 60 opioid receptor antagonist 60 ATL# [002] 60 Thiarabine 60 SERCA2a 60 c MET 60 DOS# 60 alpha antagonist 60 immune modulation 60 OncoVEX GM CSF 60 brostallicin 60 idiopathic thrombocytopenic purpura ITP 60 antiangiogenic agent 60 Cyclin E 60 PEGylated interferon 60 MGd 60 neurotrophic 60 itraconazole 60 Marqibo TM 60 mTOR mammalian target 60 Anticalins ® 60 replicon 60 NEUGENE antisense 60 P#X# antagonist 60 PCK# 60 erlotinib Tarceva 60 plectasin 60 JVRS 60 Lixivaptan 60 recurrent glioblastoma multiforme 60 agonistic human 60 subtype selective 60 fluoropyrimidine 60 samalizumab 60 adipiplon 60 cyclin dependent kinases 60 alpha folate receptor 60 prokinetic agent 60 indibulin 60 cortisol receptor 60 IMC #B 60 Pralatrexate 60 antisense compounds 59 telomerase therapeutic 59 beta lactams 59 2 inhibitor CYT# 59 Traficet EN 59 Syk 59 Factor VEGF 59 Amplimexon 59 PKC# 59 TNF α 59 TAFA# 59 orally dosed 59 Panzem NCD 59 bleomycin 59 chemotherapeutic agent 59 kinases 59 adalimumab Humira 59 5 HT6 receptor 59 immune modulatory 59 BNC# 59 biologic therapeutics 59 fulvestrant 59 Solorel TM 59 vascular disrupting 59 CUDC 59 cytotoxic agents 59 5 HT2C 59 posaconazole 59 heparanase 59 GPR# agonist 59 rxRNA 59 p# mitogen activated 59 trastuzumab Herceptin R 59 insulin sensitizer 59 OMP #R# 59 Tezampanel 59 immunotoxins 59 Bortezomib 59 V#F mutation 59 GnRH antagonist 59 long acting muscarinic 59 Pyridorin 59 ospemifene 59 CD# antibody [001] 59 investigational therapies 59 NMDA N 59 antitumor effects 59 ProMune 59 GRN# 59 PI3K Akt 59 K ras mutations 59 MPS IVA 59 DB# [003] 59 agonist compounds 59 talabostat 59 antiangiogenic activity 59 HIV integrase inhibitor 59 PLX# 59 CB1 antagonists 59 Receptor Antagonists 59 eltrombopag 59 Ridaforolimus 59 neuroprotective 59 Azixa 59 neuroprotectant 59 HCV NS5B polymerase 59 neuro inflammatory 59 VAPRISOL 59 UPLYSO 59 EGFR antibodies 59 oncolytic vaccine 59 VA# [002] 59 cyclooxygenase 59 immunotherapeutic agent 59 tumor vasculature 59 Linaclotide 59 beta lactam 59 Hedgehog inhibitor 59 demethylating agents 59 5 HT3 receptor 59 Fibroblast Growth Factor Receptor 59 anti VEGF 59 idraparinux 59 TLR Therapeutics 59 arterial thrombosis 59 Flt3 59 chemically modified siRNA 59 Plicera 59 HCD# [002] 59 immunological diseases 59 Elvitegravir 59 bicalutamide 59 peripherally restricted 59 antidiabetic drugs 59 Tarceva TM 59 Locked Nucleic Acid LNA 59 Cloretazine 59 Factor Xa 59 antithrombotic agents 59 Epidermal Growth Factor Receptor 59 Pitavastatin 59 Posiphen 59 5alpha reductase 59 acetylcholinesterase AChE 59 Anticalin 59 ponatinib 59 drug pipeline TAFA# 59 amrubicin 59 acyclovir Lauriad R 59 Virulizin ® 59 preclinical efficacy 59 lymphoid tumors 59 Pagoclone 59 CCR1 59 imexon 59 oral JAK#/JAK# inhibitor 59 calcineurin inhibitor 59 pro angiogenic 59 Hsp# chaperone 59 favorable pharmacokinetic 59 chemotherapeutic agents 59 PI3 kinase inhibitors 59 iobenguane 59 Selective Inhibitor 59 Hsp# [002] 59 B lymphocyte stimulator 59 PI3 Kinase 59 veltuzumab 59 web page www.regenerx.com 59 retinoic acid receptor 59 anemias 59 Valdoxan 59 Lenocta 59 lapatinib Tykerb 59 darinaparsin ZIO 59 hedgehog pathway 59 immunomodulatory properties 59 class anticancer quinolone 59 reversible inhibitors 59 fusion inhibitor 59 Eg5 59 positive allosteric modulator 59 DNA methyltransferases 59 immunomodulatory effects 59 PRX # 59 chemotherapy induced neutropenia 59 anticancer 59 thromboxane A2